Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ADAC Labs

This article was originally published in The Gray Sheet

Executive Summary

Law firm of Barrack, Rodos & Bacine adds to a growing list of class action suits maintaining that the company's officers issued "false and misleading" financial results from Jan. 1996 through Dec. 1998. The suit, filed in San Francisco federal court, was sparked by ADAC's Dec. 29 announcement that financial results for 1996-98 would be restated and that the adjustments would "have a material adverse impact" on fiscal 1996 and 1997 results

You may also be interested in...



ADAC Labs

Company reaches agreement-in-principle to settle a consolidated class action lawsuit alleging the company issued false and misleading financial results from January 1996 to December 1998 (1"The Gray Sheet" Jan. 18, 1999, In Brief). The settlement, which is contingent upon approval by the federal court in the Northern District of California, will award the plaintiff class $20 mil. An agreement also has also been reached in related litigation brought against current and former company executives, calling for the defendants to "contribute their respective benefits under certain directors and officers insurance policies to the company." The total pre-tax cost to the company, including legal fees, amounts to $10-11 mil., and this amount will be reflected in the company's first fiscal quarter of 2000, ended Jan. 2

ADAC Labs

Company reaches agreement-in-principle to settle a consolidated class action lawsuit alleging the company issued false and misleading financial results from January 1996 to December 1998 (1"The Gray Sheet" Jan. 18, 1999, In Brief). The settlement, which is contingent upon approval by the federal court in the Northern District of California, will award the plaintiff class $20 mil. An agreement also has also been reached in related litigation brought against current and former company executives, calling for the defendants to "contribute their respective benefits under certain directors and officers insurance policies to the company." The total pre-tax cost to the company, including legal fees, amounts to $10-11 mil., and this amount will be reflected in the company's first fiscal quarter of 2000, ended Jan. 2

Heartport Stock Up 97% In September On Acquisition Interest, New Products

Continued strong interest in minimally invasive surgery by cardiac surgeons, acquisition of competitors in the sector, a new CEO and several recent product introductions appeared to help stimulate a 97.3% gain in Heartport stock in September. The issue gained 2-1/4 points to close the month at 4-9/16.

UsernamePublicRestriction

Register

OM002075

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel